Video

Dr. Haldorsen on the Contributions of Imaging in Endometrial Cancer

Ingfrid Haldorsen, MD, University of Bergen, Haukeland University Hospital, discusses the contributions of imaging in endometrial cancer.

Ingfrid Haldorsen, MD, University of Bergen, Haukeland University Hospital, discusses the contributions of imaging in endometrial cancer.

Haldorsen says that she hopes these advances in imaging give more certainty to the surgeon regarding the stage and prognosis prior to surgery. Additionally, these advances may be able to provide more prognostic tools with which to guide adjuvant therapy after primary surgery.

Investigators are currently exploring the efficacy of various imaging technologies in the diagnosis of endometrial cancer such as PET/MRI and 3D ultrasounds. Specifically, there is a diagnostic study evaluating the accuracy of 3D ultrasounds in comparison with MRI and final histology to detect myometrial invasion of endometrial cancer (NCT03207061).

Ultimately, imaging is very important when it comes to detecting recurrent disease, Haldorsen says. Every patient should have access to imaging facilities in order to get optimal treatment, and the implications of imaging should be kept in mind by the clinician, concludes Haldorsen.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies
Audio

Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies

Jun 18th 2025 - Jun 19th 2026

online-activity
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity